| abstract |
Novel peptide mimetic compounds are provided which have useful activity as inhibitors of platelet aggregation. These compounds have the chemical structure <IMAGE> wherein x=6 to 10, y=0 to 4, Z=H, COOH, CONH2 or C1-6 alkyl, Ar=phenyl, biphenyl or napthyl, each substituted with 1 to 3 methoxy groups, or an unsubstituted phenyl, biphenyl, napthyl, pyridyl or thienyl group, and Asp=aspartic acid residue. |